Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blum HoldingsBLMH -8.84%14 EV-to-EBIT is 0.93 as of Jul. 29, 2026. GuruFocus rates BLMH with a GF Score™ of 14/100 and a GF Value™ of $0.43 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Blum Holdings ranks better than 97.24% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Blum Holdings's Enterprise Value for the quarter that ended in Sep. 2025 was $17.88 Mil.
Blum Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.83 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blum Holdings EV-to-EBIT Related Terms
Blum Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Blum Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Blum Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blum Holdings EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Blum Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Blum Holdings's EV-to-EBIT falls into.
Blum Holdings's current Enterprise Value is $13.86 Mil.
Blum Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.83 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blum Holdings (BLMH) has a EV-to-EBIT of 0.93 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Blum Holdings and its competitors. According to the industry distribution chart, Blum Holdings ranks #13 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 2.8%.
Is Blum Holdings' EV-to-EBIT too high?
Blum Holdings' current EV-to-EBIT is 0.93. The Healthcare Providers & Services industry median EV-to-EBIT is 15.74. Blum Holdings' value of 0.93 is 94.1% below this industry median. Based on the distribution chart, Blum Holdings ranks #13 out of 471 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Blum Holdings has a GF Score™ of 14/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Blum Holdings' EV-to-EBIT compare to HEWA and PMHS?
According to the Healthcare Providers & Services industry distribution chart, Blum Holdings ranks #13 out of 471 companies for EV-to-EBIT. This places Blum Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.74. Blum Holdings' value of 0.93 is 94.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.74, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blum Holdings's current EV-to-EBIT of 0.93 is 94.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Blum Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blum Holdings's current EV-to-EBIT is 0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blum Holdings stock overvalued right now?
Based on GuruFocus' analysis, Blum Holdings (BLMH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.43, compared to a current price of $0.17 — trading 61.6% below its estimated fair value. The current EV-to-EBIT is 0.93 and 94.1% below the Healthcare Providers & Services industry median of 15.74. Blum Holdings' overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Blum Holdings (BLMH), the current EV-to-EBIT is 0.93 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blum Holdings (BLMH) Overvalued in 2026?
Based on GuruFocus' analysis, Blum Holdings stock appears to be undervalued.
The current stock price of $0.17 is trading 61.6% below its estimated GF Value™ of $0.43.
GuruFocus considers Blum Holdings to be Possible Value Trap.
Key valuation signals for BLMH:
EV-to-EBIT: 0.93
GF Value™: $0.43 vs. price of $0.17 (61.6% below fair value)
Industry Position: 94.1% below the Healthcare Providers & Services median (#13 of 471)
No single metric tells the full story. See the BLMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blum Holdings Inc is a cannabis company with operations in retail, production, distribution, and cultivation, with an emphasis on providing the highest quality of medical and adult-use cannabis products. It distributes its own branded products as well as third-party products to its retail dispensaries in California under the Korova brand. The company has two reportable segments; Cannabis Retail which generates key revenue and includes cannabis-focused retail, both physical stores and non-store front delivery, and Cannabis Distribution segment which includes cannabis distribution operations.
14GF Score
Get the complete analysis for BLMH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLMH has been successfully added to your 
